Remedios Castelló

Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems

Juan Gilabert–Estellés, Luis Ramón, Francisco España et al. · Human Reproduction · 2007 · 124 citations · Full text

Medicine, Gynecology, Benign Gynecologic Disorders +12

Endorepellin In Vivo: Targeting the Tumor Vasculature and Retarding Cancer Growth and Metabolism

Gregory Bix, Remedios Castelló, Michelle Burrows et al. · JNCI Journal of the National Cancer Institute · 2006 · 110 citations

Medicine, Oncology, Pharmacology +16

Quantitative Real-Time Reverse Transcription-PCR Assay for Urokinase Plasminogen Activator, Plasminogen Activator Inhibitor Type 1, and Tissue Metalloproteinase Inhibitor Type 1 Gene Expressions in Primary Breast Cancer

Remedios Castelló, Amparo Estellés, Carlos Vázquez et al. · Clinical Chemistry · 2002 · 85 citations · Full text

Medicine, Molecular Biology, Oncology +17

Thrombin‐activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system

Esther Zorio, Remedios Castelló, Cristina Falcó et al. · British Journal of Haematology · 2003 · 75 citations

Medicine, Cardiology, Genetics +16

mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT–PCR assay

Luis Ramón, Juan Gilabert–Estellés, Remedios Castelló et al. · Human Reproduction · 2004 · 59 citations

Medicine, Gynecology, Pathobiology +9